Mootrashmari Treatment With Palasha Kshara And Ashmarihara Kwatha

Management Of Mootrashmari (Urolithiasis) With Palasha Kshara And Ashmarihara Kwatha - An Open Labelled Controlled Clinical Study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011199

Enrollment

Registered

2018-01-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient diagnosed with Mootrashmari

Interventions

Intervention1: Palasha kshara with Ashmarihara kwath for 60 days: In Group A , patient will be given Palasha kshara capsule 500 mg TDS after meal and Ashmarihara kwatha 40 ml TDS after meal for 60 d

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having age between 18 to 70 years 2) Stone size upto 10 mm 3) Patients of ashmari with controlled HTN and Diabetes Mellitus 4) Renal and Ureteric stone will be included

Exclusion criteria

Exclusion criteria: 1)Age below 18 years and above 70 years 2)Chronic Renal Failure 3)Gross Hydronephrosis 4)Acute Abdominal Pain 5)Cases which require Surgical Intervention 6)Severe Hematuria 7) Stone size more than 10 mm 8)Stone present in urinary bladder and urethera 9) Known cases of HIV, VDRL, Hepatitis, HTN ,Diabetes Mellitus,Cardiac disorders Malignancy ,TB

Design outcomes

Primary

Measure	Time frame
Relief in sign and symptoms of MootrashmariTimepoint: 60 Days	—

Secondary

Measure	Time frame
Improves quality of life of the personTimepoint: Improves quality of life of the person	—

Countries

India

Contacts

Public ContactDr T S Dudhamal

Institute for Post Graduate Training And Research Centre

drtsdudhamal@gmail.com9428671939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026